GlassScriptPhysician profile
Jay L Jordan
NPI 1265446371
$5,297.45
in general payments reported to CMS, 2019-2025
42 companies · $30.49 in 2025
The $30.49 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $839 · 2020: $685 · 2021: $1,075 · 2022: $992 · 2023: $960 · 2024: $716 · 2025: $30.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,706.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,705.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,463.56 | 2019-2023 | Xifaxan, Trulance |
| Novartis Pharmaceuticals Corporation | $482.29 | 2019-2024 | |
| Amgen INC. | $375.75 | 2019-2024 | Repatha |
| Abbvie INC. | $374.09 | 2019-2024 | |
| Qol Medical, LLC | $237.88 | 2020-2023 | Sucraid |
| Amarin Pharma, INC. | $232.07 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $161.22 | 2019-2023 | Gattex |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $156.32 | 2021-2025 | Lifevest |
| Edwards Lifesciences Corporation | $146.47 | 2023-2024 | Sapien 3 Ultra Resilia |
| Nestle Healthcare Nutrition INC. | $142.80 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $142.05 | 2020-2021 | |
| Daiichi Sankyo INC. | $137.72 | 2019-2022 | |
| Janssen Biotech, INC. | $90.84 | 2020-2022 | |
| Baxter Healthcare | $89.76 | 2023 | Hillrom - Carnation Ambulatory Monitor, Hillrom - Cardiac Ambulatory Monitor |
| Ironwood Pharmaceuticals, INC | $82.02 | 2020-2021 |
Show all 42 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Jordan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.